myhealth.alberta.ca
It is a different investigational product
Can women lose muscle on GLP1 medication
But the symptoms are the same for both
Bianchi R, Cervellini I, Porretta-Serapiglia C, Oggioni N, Burkey B, Ghezzi P et al (2012) Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy
For musculoskeletal injuries, injectable is generally more effective, but oral capsules still produce meaningful results at appropriate dosages